TMDX
TransMedics Group Inc.
Company Overview
| Mkt Cap | $4.17B | Price | $125.94 |
| Volume | 1.02M | Change | -4.26% |
| P/E Ratio | 117.6 | Open | $128.48 |
| Revenue | $441.5M | Prev Close | $131.54 |
| Net Income | $35.5M | 52W Range | $55.00 - $145.50 |
| Div Yield | N/A | Target | $141.64 |
| Overall | 58 | Value | 20 |
| Quality | 63 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyTransMedics Group Inc. (TMDX) is a leading Healthcare company in the Medical Devices industry, currently trading at $125.94 with a market capitalization of $4.17 billion. The stock is positioned in the upper portion of its trading range, demonstrating solid quality metrics with a MarketXLS quality score of 63.
Today's trading session shows TMDX with a volume of 1.02 million shares. The stock opened down 2.33% from yesterday's close of $131.54. Current analyst estimates project earnings of $2.54 per share for this year, with next year targeting $2.63.
TMDX demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including PAVM, PECN, PEYE, PACB.
Key investment considerations for TMDX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 12.5%. The stock shows expensive valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 10:47 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TMDX | $125.94 | -4.3% | 1.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |